Physician

Emergency Medicine

Dr. Julia M. Huber practices Emergency Medicine. She went to medical school at University of Kentucky College of Medicine. University of Kentucky College of Medicine is ranked 63/72 in Research/PrimaryCare. Julia Huber is also a published physician. She has 7 paper published. The most recent paper is: The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomeru-lonephritis. She accepts Medicare payments and is listed with Medicare.gov.

Publications

---

• The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomeru-lonephritis.
• IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression.
• Tim3 is upregulated and protective in nephrotoxic serum nephritis.
• The proteasome inhibitor bortezomib aggravates renal ischemia-reperfusion injury.
• p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury.
• Expression of granzyme A in human polymorphonuclear neutrophils.

Schools

---

• Virginia Commonwealth University School Of Medicine

• University Ky

Doctors Specialties

---

• Emergency Medicine

Accepted Insurances

---

Education

---

• University of Kentucky College of Medicine
• University of Virginia School of Medicine

Drug Facts

---

NPI NUMBER		1255355541
NPPES Provider LastName		HUBER
NPPES Provider FirstName		JULIA
NPPES Provider ZIPCode		403612129
NPPES Provider State		KY
Specialty Description		Emergency Medicine
Total Claim Count		94.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1255355541
Last Name Of The Provider	HUBER
First Name Of The Provider	JULIA
View All

Similar Doctors

---

	Dr. Daryl L. Emery, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert C. Wilson, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog